MADE IN INDIA COVAXIN GETS WHO NOD FOR EMERGENCY USE
The Daily Guardian|November 04, 2021
WHO says Covaxin extremely suitable for low, middle-income nations due to easy storage requirements; Central Drugs Standard Control Organisation extends Covaxin's shelf life to 12 months.

The World Health Organization (WHO) has issued emergency use listing (EUL) for India's indigenous vaccine Covaxin, adding to a growing portfolio of vaccines validated by WHO for prevention of Covid-19. The WHO said in a tweet that the Technical Advisory Group, convened by World Health Organisation (WHO), has determined that the Hyderabad-based Bharat Biotech's Covid-19 vaccine meets WHO standards for protection against Covid-19.

WHO has granted emergency use listing (EUL) to COVAXIN® (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of #COVID19, WHO said in a tweet.

The Technical Advisory Group, convened by WHO and made up of regulatory experts from around the world, has determined that the Covaxin vaccine meets WHO standards for protection against #COVID19, that the benefit of the vaccine far outweighs risks and the vaccine can be used, it added.

The global health body said that the Covaxin vaccine was also reviewed by WHO's Strategic Advisory Group of Experts on Immunization (SAGE), and recommended the use of this vaccine in two doses, with a dose interval of four weeks, in all age groups 18 and above.

Available data on vaccination of pregnant women with the Covaxin vaccine are insufficient to assess vaccine safety or efficacy in pregnancy; studies in pregnant women are planned, including a pregnancy sub-study and a pregnancy registry, WHO said.

The WHO has said that Covaxin is extremely suitable for low and middle-income countries due to easy storage requirements. The UN health body said that Covaxin was found to have 78% efficacy against Covid-19 of any severity, 14 or more days after the second dose. Covaxin was found to have 78% efficacy against of any severity, 14 or more days after the second dose, and is extremely suitable for low- and middle-income countries due to easy storage requirements,” WHO said in a tweet on Wednesday.

Continue reading your story on the app

Continue reading your story in the newspaper

MORE STORIES FROM THE DAILY GUARDIANView All

US Supreme Court to get first Black woman judge

The President of the United States will nominate a Black woman as a judge to the Supreme Court for the first time in history, filling the vacancy left by the retiring Justice Stephen Breyer.

1 min read
The Daily Guardian
January 29, 2022

Covid-19: Haryana inoculates 1,000,000 health and frontline workers

In wake of acute spike in fresh Covid-19 cases in Haryana, the state government is on toes to strengthen the vaccination process in order to tackle the fatal disease.

1 min read
The Daily Guardian
January 29, 2022

Post-poll violence: CBI arrests 7 people accused of killing Bengal BJP worker

CBI has announced a cash reward of Rs 50,000 each for information on the five absconding accused in the murder case of another BJP worker, namely Abhijit Sarkar.

1 min read
The Daily Guardian
January 29, 2022

India beat China 2-0 to finish 3rd in Women's Asia Cup

Goals by Sharmila Devi and Gurjit Kaur helped the Savita-led side end the tournament with a third-place finish.

2 mins read
The Daily Guardian
January 29, 2022

Can advocates of'united-front' rally around Mamata Banerjee?

Mamata Banerjee has to dispel the perception of being a minority appeaser, autocratic and intolerant. Above all, she must reach out to Rahuland Kejriwal, seek their support, and offer them significant roles befitting their stature. But, will she?

5 mins read
The Daily Guardian
January 29, 2022

We Will Uphold The Principle Of NATO's Open Door: Blinken

The US on Wednesday rejected Russia's call to bar Ukraine from becoming a part of NATO.

1 min read
The Daily Guardian
January 28, 2022

International Alliance Of MPs Calls For Blacklisting Of Chinese Firms

An international cross-party network of legislators across the European Union, the United Kingdom, India, Australia, and Canada have called on their governments to block investors from bankrolling firms perpetrating forced labor abuses in China's Xinjiang province.

2 mins read
The Daily Guardian
January 28, 2022

Students have the fundamental right to protest: An analysis in the light of recent RRB-NTPC result controversy

Recently, In Bihar, for the last 3-4 days, there have been incidents of youth and students stopping trains and blocking railway tracks at different Railway stations. 

5 mins read
The Daily Guardian
January 28, 2022

TURNING LOVE FOR DOGS INTO A PROFESSION

WORKING WITH ANIMALS

2 mins read
The Daily Guardian
January 28, 2022

TMC to go to Parliament, likely to seek Dhankhar's removal

On Thursday, TMC supremo Mamata Banerjee, from her Kalighat residence in Kolkata, presided over a party’s virtual meeting where the decision of taking action against the Governor was unanimously taken.

2 mins read
The Daily Guardian
January 28, 2022
RELATED STORIES

Covishield, Covaxin Receive Conditional Market Approval

The Drugs Controller General of India (DCGI) has given its nod to the market authorisation of two Covid vaccines — Bharat Biotech's Covaxin and Serum Institute of India's (SII's) Covishield --for use in the adult population, subject to certain conditions, said a Union health ministry statement on Thursday.

1 min read
Business Standard
January 28, 2022

Covishield, Covaxin prices likely to be capped at ₹ 275

Additional ₹150 could be service charge; regular market nod expected soon

2 mins read
Business Standard
January 27, 2022

Health staff, elderly to get 3rd vaccine jab from today

NEW DELHI: High-risk heath and front line workers, and senior citizens with co-morbidities can from today walk into any vaccination centre for inoculation with a third precautionary dose, provided the second dose was taken nine months ago. They can also book a slot online through the government's COWIN portal.

2 mins read
Hindustan Times
January 10, 2022

To boost fight, ‘precaution dose' of vax begins today

‘SMSes Sent to Over 1 Crore Beneficiaries’

1 min read
The Times of India Mumbai
January 10, 2022

The shelf life of vaccines

How long does a vaccine stay potent? This depends on stability tests, and can be extended based on data, as has happened with Covishield and Covaxin. What data are analysed, and how is shelf life determined?

4 mins read
The Indian Express Delhi
January 04, 2022

Expect a slow but steady start to teen vaccination

Day1 to see a few hundred shots administered at each site

3 mins read
Business Standard
January 03, 2022

Experts to get cracking, now

To decide which vaccine is to be given to kids; which vaccine will be the booster dose; and what will be the gap between the last dose and the 'precautionary shot for elderly

2 mins read
The Free Press Journal
December 27, 2021

Vaccine for 15-17 age group, booster for frontline staff

Additional shots also for 60+; regulator clears Covaxin for 12+ group

2 mins read
The New Indian Express
December 26, 2021

PM Modi announces vaccine for children, ‘precaution' dose for health staff, elderly

India logs 415 Omicron cases; Bharat Biotech’s Covaxin gets emergency nod for children aged 12-18

4 mins read
Millennium Post Delhi
Delhi 26 December 2021

NO KIDDING, JAB FOR 12+

Covaxin allowed for emergency use in children above 12 years; decision will go a long way in bringing kids back into the classroom and the playfield. Two more vaccines for children are in the making

2 mins read
The Free Press Journal
December 26, 2021